Structural Basis for the Regulation of PPARγ Activity by Imatinib
Sign Up to like & getrecommendations! Published in 2019 at "Molecules"
DOI: 10.3390/molecules24193562
Abstract: Imatinib is an effective anticancer drug for the treatment of leukemia. Interestingly, when an FDA-approved drug library was tested for agents that block peroxisome proliferator-activated receptor γ (PPARγ) phosphorylation at Ser245 to evaluate possibilities of… read more here.
Keywords: ppar; structural basis; regulation ppar; basis regulation ... See more keywords